Small cell lung cancer
Emerging therapies for small cell lung cancer
... Currently, chemotherapy remains the standard treatment for first- and second-line management of small cell lung cancer (SCLC). Immunotherapy has made progress in the treatment of SCLC, and ...
11
Vaccines in Non Small Cell Lung Cancer
... Non-small cell lung cancer stage IIIB and IV patients were enrolled between 2000 and 2002 by centers of Canada and the United Kingdom, including a total of 171 ...
6
Anterior Mediastinal Mass in a Young Marijuana Smoker: A Rare Case of Small-Cell Lung Cancer
... At 22 years of age, this patient was quite young to be diagnosed with small-cell lung cancer. In the United States, there have been 0.03 cases per 1000 of lung cancer reported in ...
5
Immunotherapy in extensive small cell lung cancer
... Small cell lung cancer which constitutes about 15% of lung cancers is pathobiologically and clinically distinct from non small cell ...by small cells with scant ...
8
An immunohistochemical study of cyclin dependent kinase 5 (CDK5) expression in non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker
... in cancer is ...in cancer tissue ...prostate cancer, breast cancer, medullary thyroid carcinoma, pituitary adenoma, and hepatocellular carcinoma, and CDK5 gene amplification was found in ...
8
Markers of small cell lung cancer
... Lung cancer is the most common cancer world ...into small cell lung cancer (SCLC) and non- small cell lung cancer ...the lung itself, ...
5
Combination Chemotherapy for Small Cell Lung Cancer
... Combination Chemotherapy for Small Cell Lung Cancer ORIGINAL ARTICLE Combination Chemotherapy for Small Cell Lung Cancer A W Sufarlan, MRCP B M Z Zainudin, MRCP Respiratory Unit, Department of Medicin[.] ...
5
Surgical treatment in non small cell lung cancer with pulmonary oligometastasis
... Primary lung cancer is one of the most common malig- nant tumors and is still the leading cause of cancer- related death in many countries [1, ...of lung cancer is increasing every ...
5
Non-small cell to small cell lung cancer on PD-1 inhibitors: two cases on potential histologic transformation
... non-small cell lung cancer (NSCLC) to small cell lung cancer (SCLC) is a well-recognized mechanism of resistance in EGFR-mutant adeno- carcinoma upon treatment with ...
6
Prognostic value of angiopoietin 2 in non small cell lung cancer patients: a meta analysis
... Lung cancer is the leading cause of cancer deaths world- wide, whose 5-year survival rate is only 16 % ...of lung cancer; unfortunately, the incidence and mortality of lung ...
9
Safety and Efficacy of Racotumomab Alum Vaccine as Second Line Therapy for Advanced Non Small Cell Lung Cancer
... of lung cancer according its biology, therapy and prognosis: non-small cell lung cancer (NSCLC) and small cell lung ...all lung cancer ...
8
Crizotinib in non small cell lung cancer
... [1] Scagliotti, G.V., Parikh, P., Von Pawel, J., Biesma, B., Vansteenkiste, J., Manegold, C., Serwatowski, P., Gatze- meier, U., Digumarti, R., Zukin, M., Lee, J.S., Mellemga- ard, A., Park, K., Patil, S., Rolski, J., ...
5
An adherent subline of a unique small cell lung cancer cell line downregulates antigens of the neural cell adhesion molecule
... Small-cell lung cancer (SCLC) lines are distinguished from non-small-cell lung cancer (NSCLC) lines by their growth in floating aggregates, in contrast to the ...
8
Prognostic value of metformin for non small cell lung cancer patients with diabetes
... of small cell lung cancer (SCLC), found that metformin significantly reduced the recurrence rate of SCLC ( p = ...prostate cancer in a long term [10, 12, ...
5
Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients
... Results: The total study population consisted of 197 patients; 92 (46.7%) were COPD patients and 105 (53.3%) were non-COPD patients. The median survival in the non-COPD group was 11.5 months, compared to 9.2 months in ...
8
Elevated expression of podoplanin and its clinicopathological, prognostic, and therapeutic values in squamous non-small cell lung cancer
... Shanghai Cancer Center (FUSCC) from January 2012 to December 2012 were identified, including 101 patients with ...on Cancer (AJCC), 7th edition, stage I–IV SqNSCLC confirmed by surgical ...
12
The roles of metallothioneins in carcinogenesis
... ovarian cancer [22, 118], breast cancer [119, 120], small cell lung cancer [121], non-small cell lung cancer [122], renal cell carcinoma [123, ...
20
Diabetes insipidus and panhypopituitarism as a first presentation of silent adenocarcinoma of lung: a case report and literature review
... advanced cancer and associated with widespread metasta- ses, typically affecting elderly patients, especially those aged 60–70 years ...and lung are the most common sites of the primary tumor, accounting ...
7
Original Article Comparison of smear cytology with histopathology in the ultrasonography-or computed tomography-guided biopsy of lung neoplasms
... showed lung cancer by smear cytology failed to further distinguish small cell lung cancer and non small cell lung cancer (corresponding ...
7
Original Article The identification of genes associated with NSCLC prognosis based on an integrated bioinformatics analysis
... pancreatic cancer and correlated with patients’ poor prognosis ...non-small-cell lung cancer stage I-IIIA, a pre- liminary report by immunohistochemical assay ...in cancer tissue ...
8